Methodology of Purification of Inactivated Cell-Culture-Grown SARS-CoV-2 Using Size-Exclusion Chromatography
Authors:
- Anastasia A. KovpakAKAnastasia A. Kovpak
- Anastasia N. PiniaevaAPAnastasia N. Piniaeva
- Oleg A. GerasimovOGOleg A. Gerasimov
- Irina O. TcelykhITIrina O. Tcelykh
- Mayya Y. ErmakovaMEMayya Y. Ermakova
- Anna N. ZyrinaAZAnna N. Zyrina
- Dmitry V. DanilovDDDmitry V. Danilov
- Yury Y. IvinYIYury Y. Ivin
- Liubov I. KozlovskayaLKLiubov I. Kozlovskaya
- Aydar A. IshmukhametovAIAydar A. Ishmukhametov
Open Access
Abstract
Various types of COVID-19 vaccines, including adenovirus, mRNA, and inactivated ones, have been developed and approved for clinical use worldwide. Inactivated vaccines are produced using a proven technology that is widely used for the production of vaccines for the prevention and control of infectious diseases, including influenza and poliomyelitis. The development of inactivated whole-virion vaccines commonly includes several stages: the production of cellular and viral biomass in cell culture; inactivation of the virus; filtration and ultrafiltration; chromatographic purification of the viral antigen; and formulation with stabilizers and adjuvants. In this study, the suitability of four resins for Size-Exclusion Chromatography was investigated for the purification of a viral antigen for the human COVID-19 vaccine.Keywords
This publication has 19 references indexed in Scilit:
- Development of an inactivated vaccine candidate for SARS-CoV-2Science, 2020
- Cell entry mechanisms of SARS-CoV-2Proceedings of the National Academy of Sciences, 2020
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptorNature, 2020
- Scale‐down of the inactivated polio vaccine production processBiotechnology and Bioengineering, 2012
- An international technology platform for influenza vaccinesVaccine, 2011
- Expression of SARS-coronavirus spike glycoprotein in Pichia pastorisVirus Genes, 2008
- Specific mucosal IgA immunity in turkey poults infected with turkey coronavirusVeterinary Immunology and Immunopathology, 2002
- The Lowry Method for Protein Quantitation1994
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970